TRPM4 and stroke disorder: Although many achievements have been made, the latest clinical research results demonstrated that GLC at a safe dose could not significantly improve the prognosis of stroke patients (Sheth et al., 2016), exemplifying the limitations of GLC treatment and showing the importance of developing new treatments that target TRPM4.